An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk. The recommendation is based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.

A team of researchers including investigators from Mayo Clinic has identified a technology to address the problem of false positives in computed tomography (CT)-based lung cancer screening. The team’s findings are published in the current issue of PLOS One.

Intelerad Medical Systems announced the launch of its artificial intelligence (AI) initiative along with the expansion of its partnership with Blackford to offer Blackford Platform, a single platform to access and manage multiple medical image analysis applications.

Konica Minolta Healthcare Americas Inc. announced that two clinical studies utilizing the company’s Dynamic Digital Radiography (DDR) X-ray technology were presented at the American Thoracic Society (ATS) 2018 Annual Meeting, May 18-23 in San Diego. Dynamic Digital Radiography, currently under development, is a new modality that utilizes conventional X-ray images and Konica Minolta's proprietary software platform to create X-ray in Motion.

The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial burden that many cancer patients endure when trying to get their insurer’s approval for physician-recommended proton radiation therapy. The report – Cancer Care Denied: The Broken State of Patient Access to Proton Therapy – calls on insurance commissioners in all 50 states to adopt and enforce the principles of a Cancer Patients’ Timely Treatment Bill of Rights and hold insurers accountable for providing fair, timely and transparent access to cancer treatment.

Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery (SRS) Brain, with a plan she created using the Accuray Precision Treatment Planning System. Schmitt, a medical physicist at Heidelberg University Hospital, Germany, developed a plan for delivery on the CyberKnife M6 System, a device designed from the ground up to deliver SRS treatments with precision and accuracy, and without an invasive frame.

Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published study in JNCCN – Journal of the National Comprehensive Cancer Network. The study was led by Kathryn Ruddy, M.D., MPH, director of cancer survivorship for the Department of Oncology, Mayo Clinic Cancer Center.

May 23, 2018 — Mach7 Technologies and Client Outlook announced their expanded partnership to focus on today’s prevalent ...